Ebstein Anomaly — #2 Pathophysiology: Neonate without PDA

Date
October 30, 2025
URL
https://x.com/WithAScalpel/status/1983865872323117448
Categories
Ebstein Anomaly

Ebstein Anomaly — #2 Pathophysiology: Neonate without PDA

image

Baseline lesion. Ebstein anomaly results from failed delamination of the septal and inferior tricuspid leaflets with apical displacement of the hinge line, atrialization of the proximal RV, and a diminutive, often myopathic functional RV. Severe TR and a right-to-left interatrial shunt (PFO/ASD) are common features [1, 2]. PubMed+1

Immediate postnatal state (high PVR, limited RV→PA flow). In the first hours of life, physiologically high PVR imposes a large afterload on the small, inefficient RV. Combined with severe TR, this yields poor antegrade pulmonary flow and elevated RA pressure; in the absence of a ductal pathway, pulmonary blood flow depends entirely on what the RV can deliver. The interatrial pressure gradient therefore favors R→L shunting with systemic desaturation and cyanosis [1, 3]. PubMed+1

Evolution as PVR falls. Over days, falling PVR can unmask or restore RV→PA forward flow—provided the pulmonary valve is anatomically permissive and the functional RV has sufficient contractile reserve. In a comparative series of neonates with no initial RV forward flow, those with a normal pulmonary valve (larger annulus) typically established antegrade flow around ~10 days and more often achieved bi- or 1½-ventricle circulation than those with abnormal valves [4]. PubMed

Determinants of trajectory.

  • RV performance/TR severity. The balance between RV systolic capacity and TR governs whether the fall in PVR translates into meaningful forward flow [1, 2]. PubMed+1
  • Pulmonary valve morphology and annulus size. A normal valve/large annulus predicts recovery of antegrade flow and better survival [4]. PubMed
  • Interatrial communication. A large, nonrestrictive PFO/ASD decompresses the RA but sustains hypoxemia; a restrictive septum risks inadequate LV preload and low output [1]. PubMed
  • Pulmonary vascular tone. Hypoxia, acidosis, and agitation raise PVR and worsen the physiology; gentle ventilation, adequate oxygenation, and normothermia lower PVR and support transition [1]. PubMed

Functional pulmonary atresia. When PVR is high and RV systolic pressure is low, the effective physiology may mimic pulmonary atresia despite a patent valve—functional pulmonary atresia—which can reverse as PVR falls and RV performance improves [1, 5]. PubMed+1

Hemodynamics and imaging. Expect markedly elevated RA pressure, reduced Qp:Qs, and systemic output that relies on interatrial mixing for LV preload. Echocardiography typically shows a massively dilated RA, atrialized RV, a small functional RV with low stroke volume, severe TR, and little or no antegrade PA color-Doppler signal while PVR remains high [1]. PubMed

Management implications (principles for the “no-PDA” neonate).

  • Prostaglandin E1 does not improve pulmonary blood flow when no ductal pathway exists; focus instead on lowering PVR (oxygenation, normocapnia/mild alkalosis, sedation, normothermia) and optimizing RV preload/contractility while maintaining sinus rhythm [1, 3]. PubMed+1
  • Serial reassessment during the natural PVR decline is essential; if RV→PA flow emerges (often within ~1–2 weeks in those with a normal PV), progressive improvement in oxygenation follows [4]. PubMed
  • Interatrial septum management. If LV preload is limited by a restrictive atrial septum with low systemic output, relief (e.g., balloon atrial septostomy) can be lifesaving; conversely, once stable antegrade flow is established, a large ASD may perpetuate desaturation and later warrant closure [1]. PubMed
  • Escalation and surgical pathways. When transition fails—e.g., persistent functional atresia, torrential TR with severe RV dysfunction—care is individualized. Options range from temporizing strategies to definitive neonatal surgery; contemporary reviews emphasize tailoring intervention to anatomy + physiology along the spectrum from biventricular repair to single-ventricle–leaning approaches [3, 6]. PubMed+1

References

[1] Kumar TKS. Ebstein's anomaly in the neonate. Indian J Thorac Cardiovasc Surg. 2021;37(Suppl 1):17-25. doi:10.1007/s12055-020-00942-z. PubMed

[2] Wackel PL, Dearani JA, Cetta F. Neonatal Ebstein repair—where are we now? Ann Transl Med. 2017;5(5):109. doi:10.21037/atm.2017.01.19. PubMed

[3] Jaquiss RDB, Imamura M. Management of Ebstein’s anomaly and pure tricuspid insufficiency in the neonate. Semin Thorac Cardiovasc Surg. 2007;19(3):258-263. doi:10.1053/j.semtcvs.2007.07.004. PubMed

[4] Baek JS, Yu JJ, Im YM, Yun T-J. Outcomes of neonatal Ebstein’s anomaly without right ventricular forward flow. J Thorac Cardiovasc Surg. 2016;152(2):516-521. doi:10.1016/j.jtcvs.2016.03.084. PubMed

[5] Azeka E, et al. Functional atresia of the pulmonary valve in neonates with Ebstein’s anomaly. Arq Bras Cardiol. 1992;59(4):217-220. (PubMed PMID: 1307457). PubMed

[6] Sainathan S, Tang GH, Andrianopoulos N. Ebstein’s anomaly: contemporary management strategies. Ann Cardiothorac Surg. 2020;9(3):229-239. PMC